Literature DB >> 20023949

Densely packed Gd(III)-chelates with fast water exchange on a calix[4]arene scaffold: a potential MRI contrast agent.

Daniel T Schühle1, Miloslav Polásek, Ivan Lukes, Thomas Chauvin, Eva Tóth, Jürgen Schatz, Ulf Hanefeld, Marc C A Stuart, Joop A Peters.   

Abstract

A pyridine-N-oxide functionalized DOTA analogue has been conjugated to a calix[4]arene and the corresponding Gd-complex was characterized with respect to its suitability as MRI contrast agent. The compound forms spherical micelles in water with a cmc of 35 microM and a radius of 8.2 nm. The relaxivity of these aggregates is 31.2 s(-1) mM(-1) at 25 degrees C and 20 MHz, which corresponds to a molecular relaxivity of 125 s(-1) mM(-1). The high relaxivity mainly originates from the short tau(M) (72.7 ns) and the size of the micelles. The interaction with bovine serum albumin (BSA) was studied and an observed relaxivity of up to 40.8 s(-1) mM(-1) (163.2 s(-1) mM(-1) per binding place) at 20 MHz and 37 degrees C was found in the presence of 2.0 mM protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20023949     DOI: 10.1039/b917673j

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  3 in total

1.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

2.  Luminescence Properties of Self-Aggregating TbIII-DOTA-Functionalized Calix[4]arenes.

Authors:  Florian Mayer; Sriram Tiruvadi Krishnan; Daniel T Schühle; Svetlana V Eliseeva; Stéphane Petoud; Éva Tóth; Kristina Djanashvili
Journal:  Front Chem       Date:  2018-01-30       Impact factor: 5.221

3.  Bifunctional chelates optimized for molecular MRI.

Authors:  Erik C Wiener; Marie-Caline Abadjian; Raghvendra Sengar; Luce Vander Elst; Christoffel Van Niekerk; Douglas B Grotjahn; Po Yee Leung; Christie Schulte; Curtis E Moore; Arnold L Rheingold
Journal:  Inorg Chem       Date:  2014-06-16       Impact factor: 5.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.